BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9656899)

  • 1. Pain preceding recurrent head and neck cancer.
    Wong JK; Wood RE; McLean M
    J Orofac Pain; 1998; 12(1):52-9. PubMed ID: 9656899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain complaint as the first symptom of oral cancer: a descriptive study.
    Cuffari L; Tesseroli de Siqueira JT; Nemr K; Rapaport A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):56-61. PubMed ID: 16831673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of treatment results for floor-of-mouth cancer.
    Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of syncope from head and neck cancer.
    Papay FA; Roberts JK; Wegryn TL; Gordon T; Levine HL
    Laryngoscope; 1989 Apr; 99(4):382-8. PubMed ID: 2927214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndrome of inappropriate antidiuretic hormone secretion due to recurrent oral cancer.
    Danielides V; Milionis HJ; Karavasilis V; Briasoulis E; Elisaf MS
    B-ENT; 2005; 1(3):151-3. PubMed ID: 16255500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer in the differential diagnosis of orofacial pain.
    Marshall JA; Mahanna GK
    Dent Clin North Am; 1997 Apr; 41(2):355-65. PubMed ID: 9142489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presenting symptoms of head and neck cancer.
    Robertson MS; Hornibrook J
    N Z Med J; 1982 May; 95(708):337-41. PubMed ID: 6954395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of orofacial pain of patients with different stages of precancer and oral cancer.
    Yang Y; Zhang P; Li W
    Sci Rep; 2017 Mar; 7(1):203. PubMed ID: 28303010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant lesions presenting as symptoms of craniomandibular dysfunction.
    Drum RK; Fornadley JA; Schnapf DJ
    J Orofac Pain; 1993; 7(3):294-9. PubMed ID: 9116629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome of inappropriate antidiuretic hormone secretion associated with oral squamous cell carcinoma.
    Thompson M; Adlam DM
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):216-9. PubMed ID: 12054712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer.
    Leach BC; Kulbersh JS; Day TA; Cook J
    Dermatol Surg; 2008 Apr; 34(4):483-97. PubMed ID: 18248467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of recurrent head and neck tumours following flap reconstructive surgery.
    Tomura N; Watanabe O; Hirano Y; Kato K; Takahashi S; Watarai J
    Clin Radiol; 2002 Feb; 57(2):109-13. PubMed ID: 11977942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of treatment results for oral tongue cancer.
    Sessions DG; Spector GJ; Lenox J; Haughey B; Chao C; Marks J
    Laryngoscope; 2002 Apr; 112(4):616-25. PubMed ID: 12150512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indication for epidural morphine for the relief of intractable pain in advanced oral cancer: report of four cases.
    Kayahara H; Hamakawa H; Fukuzumi M; Tanioka H
    Br J Oral Maxillofac Surg; 2000 Oct; 38(5):546-9. PubMed ID: 11010793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
    Wong LY; Wei WI; Lam LK; Yuen AP
    Head Neck; 2003 Nov; 25(11):953-9. PubMed ID: 14603456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
    Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
    Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.